GHK-Cu and Epitalon Together: What Is Known
GHK-Cu and Epitalon taken together: what each one is, how each is regulated, and what is known about combining them.
Timing, interactions and safety
Evidence for the combination
No studies tested these together (PubMed search: 2 results, 2 Oct 2026).
Side by side
Showing 8 of 11 fields where the two differ. WADA, Half-life, Evidence strength are the same or both unknown.
| Field | GHK-Cu | Epitalon |
|---|---|---|
| Class | Copper tripeptide | Tetrapeptide |
| Also called | copper peptide, copper tripeptide-1, GHK | Epithalon, epithalamin, N-acetyl epitalon |
| Category | Skin & hair | Longevity |
| FDA status | Injectable off Category 2 (Apr 2026) | PCAC voted 7–5 for 503A (Jul 2026) |
| PCAC vote, Jul 2026 | Not on the Jul 2026 agenda | PCAC voted 7–5 for the 503A list (Jul 2026); not finalized |
| WADA | WADA status unclearGHK-Cu: This is not named on the 2026 list. The catch-all class S0 prohibits any drug with no approval anywhere for human use, so it would be banned if no health authority has approved it, but we have not verified that for this substance. | WADA status unclearEpitalon: This is not named on the 2026 list. The catch-all class S0 prohibits any drug with no approval anywhere for human use, so it would be banned if no health authority has approved it, but we have not verified that for this substance. |
| Half-life | No published half-life foundPubMed search, 11 Oct 2026 | No published half-life foundPubMed search, 11 Oct 2026 |
| Evidence strength | Human RCT evidence, 4 of 4Strongest: Archives of facial plastic surgery 2006, PMID 16847171 | Human RCT evidence, 4 of 4Strongest: Neuro endocrinology letters 2002, PMID 12195242 |
| Human studies we summarised | 5 human (2 randomized or controlled) of 15 summarised | 1 human (1 randomized or controlled) of 13 summarised |
| Typical study doses |
|
|
| Vial sizes sold | 50 mg, 100 mg, 200 mg | 10 mg, 50 mg, 100 mg |
Epitalon: lifespan and cell studies
In mice, Epitalon increased the life span of the last 10% of survivors by 13.3% and maximum life span by 12.3%.[16]
In human fetal fibroblast culture, Epithalon induced telomerase expression and enzyme activity.[25]
An early report in people with retinal degeneration claimed a positive clinical effect in 90% of the cases.[13]
GHK-Cu: tissue repair and cosmetics
In rats with ischemic open wounds, wound area had decreased by 64.5% on day 13 with topical GHK-Cu, against 45.6% with vehicle.[26]
In a trial in laser-resurfaced skin, computer analysis and blinded evaluators found no statistically significant difference between groups for earlier resolution of erythema.[3]
Together
The Epitalon plus GHK-Cu search returned 2 PubMed records, none classed as a study of the pair.
Calculated from pubmed query (epitalon[tiab] OR epithalon[tiab] OR epithalamin[tiab]) AND ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]); search date 2026-10-02; records returned 2; records classed as study of the pair 0. Formula: Counts copied from the combinations dataset (web/src/data/combinations.json, key epitalon__ghk-cu); no arithmetic applied.
WADA's S0 clause prohibits at all times any substance with no current approval for human therapeutic use. It is the clause that would reach an unapproved peptide.[2]
FDA removed Epitalon from category 2 after the nominators withdrew and scheduled a committee consultation.[27]
Common questions
Can you take GHK-Cu and Epitalon together?
No study of the combination was found. The Epitalon results cited come from mice, cell culture and older clinical reports.[16]
GHK-Cu or Epitalon: what is each studied for?
The GHK-Cu review calls the human data thin, and Epitalon's results come from mice, cells and older clinical reports.[28]
Sources
- 1FDA gives notice that 12 peptides will be removed from Category 2 (nominations withdrawn)FDA · 2026fda.govAccessed 2 Oct 2026
- 2World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 3Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin.Archives of facial plastic surgery · 2006PMID 16847171Accessed 2 Oct 2026
- 4Tripeptide-copper complex GHK-Cu (II) transiently improved healing outcome in a rat model of ACL reconstruction.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2015PMID 25731775Accessed 2 Oct 2026
- 5PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) (431 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 6PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (humans[mh] OR patients[tiab] OR volunteers[tiab]) (150 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 7PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (randomized[tiab] OR clinical trial[pt] OR split-face[tiab]) (8 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 8PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (wound[tiab] OR hair[tiab] OR skin[tiab] OR wrinkle*[tiab]) (123 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 9PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (2 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 10PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (rat[tiab] OR mice[tiab] OR rats[tiab] OR animal[tiab]) (80 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 11PubMed search: ("GHK-Cu"[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (facial[tiab] OR cream[tiab] OR photodamage[tiab] OR volunteers[tiab] OR women[tiab]) (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 12PubMed search: ("GHK-Cu"[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (hair[tiab] OR alopecia[tiab]) (16 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 13Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa.Neuro endocrinology letters · 2002PMID 12195242Accessed 2 Oct 2026
- 14Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice.In vivo (Athens, Greece) · 2006PMID 16634527Accessed 2 Oct 2026
- 15[Effect of epitalon and melatonin on life span and spontaneous carcinogenesis in senescence accelerated mice (SAM)].Voprosy onkologii · 2005PMID 15909815Accessed 2 Oct 2026
- 16Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice.Biogerontology · 2003PMID 14501183Accessed 2 Oct 2026
- 17PubMed search: (epitalon[tiab] OR epithalon[tiab] OR epithalamin[tiab]) (165 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 18PubMed search: (epitalon[tiab] OR epithalon[tiab] OR epithalamin[tiab]) AND (humans[mh] OR patients[tiab] OR randomized[tiab]) (58 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 19PubMed search: (epitalon[tiab] OR epithalon[tiab] OR epithalamin[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (0 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 20PubMed search: epitalon[tiab] AND (mice[tiab] OR rats[tiab] OR "life span"[tiab] OR lifespan[tiab]) (31 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 21PubMed search: (epitalon[tiab] OR epithalon[tiab] OR epithalamin[tiab]) AND ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab])PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 22Advisory committee backs 6 of 7 peptides for the 503A listNCPA · 2026ncpa.org
- 23PubMed search: ("GHK-Cu"[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (38 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 24PubMed search: (epitalon[tiab] OR epithalon[tiab] OR epithalamin[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 25Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.Bulletin of experimental biology and medicine · 2003PMID 12937682Accessed 2 Oct 2026
- 26The effect of topical tripeptide-copper complex on healing of ischemic open wounds.Veterinary surgery : VS · 2003PMID 14648529Accessed 2 Oct 2026
- 27Official web pageOfficial web page · web page
- 28A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials.Archives of internal medicine research · 2026PMID 42787770Accessed 2 Oct 2026
Found an error? Report a correction.